Medicare Enrolled

Dr. Leila Bostan Shirin, M.D.

Neurology · Fort Worth, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Research-focused
713 GRAINGER ST, Fort Worth, TX 76104
8173363968
In practice since 2016 (9 years)
NPI: 1770933434 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bostan Shirin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bostan Shirin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bostan Shirin

Dr. Leila Bostan Shirin is a neurology in Fort Worth, TX, with 9 years in practice. Based on federal Medicare data, Dr. Bostan Shirin performed 4,533 Medicare services across 1,161 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bostan Shirin received a total of $35,690 from 50 pharmaceutical and/or device companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bostan Shirin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice▲ Top 13% volume in TX$ $35,690 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,533
Medicare services
Top 13% in TX for neurology
1,161
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~504 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit3,000$5$9
Office visit, established patient, complex (40-54 min)423$129$219
Initial hospital admission, high complexity344$135$398
Hospital follow-up visit, high complexity281$93$198
Office visit, established patient (30-39 min)120$93$164
Hospital follow-up visit, moderate complexity116$62$146
Measurement of brain wave activity (eeg), awake and drowsy57$294$550
New patient office visit, complex (60-74 min)53$165$350
Evaluation of neuropsychological test, first hour46$102$280
Administration of psychological or neuropsychological test by technician, first 30 minutes46$26$150
Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional26$103$600
Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional21$159$650
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$35,690
Total received (2019-2024)
Avg $5,948/year across 6 years
Top 12% in TX for neurology
50
Companies
362
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Scientific / Research
Research funding and grants
$20,000 (56.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,609 (26.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,080 (17.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,500
2023
$5,582
2022
$2,967
2021
$553
2020
$20,000
2019
$87

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$12,854
Medtronic USA, Inc.
$10,000
Kyowa Kirin, Inc.
$6,317
ABBVIE INC.
$1,059
Medtronic, Inc.
$571
Biogen, Inc.
$504
ACADIA Pharmaceuticals Inc
$462
UCB, Inc.
$412
AbbVie Inc.
$327
Abbott Laboratories
$293
Lilly USA, LLC
$220
Alexion Pharmaceuticals, Inc.
$219
MDD US Operations, LLC
$163
SK Life Science, Inc.
$132
Eisai Inc.
$127
Genentech USA, Inc.
$124
Amgen Inc.
$122
Teva Pharmaceuticals USA, Inc.
$117
ARGENX US, INC.
$116
Ipsen Biopharmaceuticals, Inc
$108
Takeda Pharmaceuticals U.S.A., Inc.
$103
MITSUBISHI TANABE PHARMA AMERICA, INC.
$96
Nevro Corp.
$93
Akcea Therapeutics, Inc.
$87
UPSHER-SMITH LABORATORIES LLC
$86
Merz Pharmaceuticals, LLC
$72
Avion Pharmaceuticals
$72
Novartis Pharmaceuticals Corporation
$68
PFIZER INC.
$67
Lundbeck LLC
$61
Amneal Pharmaceuticals LLC
$59
Acorda Therapeutics, Inc
$52
Neurocrine Biosciences, Inc.
$46
EMD Serono, Inc.
$46
Supernus Pharmaceuticals, Inc.
$40
Horizon Therapeutics plc
$39
JAZZ PHARMACEUTICALS INC.
$39
Currax Pharmaceuticals LLC
$38
Catalyst Pharmaceuticals, Inc.
$38
AstraZeneca Pharmaceuticals LP
$37
Biohaven Pharmaceutical Holding Company Ltd.
$25
CATALYST PHARMACEUTICALS, INC.
$25
Alnylam Pharmaceuticals Inc.
$24
Otsuka America Pharmaceutical, Inc.
$22
ANI Pharmaceuticals, Inc.
$21
NS Pharma, Inc.
$20
CSL Behring
$18
Azurity Pharmaceuticals, Inc.
$18
Jazz Pharmaceuticals Inc.
$15
ARBOR PHARMACEUTICALS, INC.
$13
Top 3 companies account for 81.7% of total payments
Associated products mentioned in payments ›
ACTIVA · ACTIVA PC · AJOVY · AMYVID · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · BRILINTA · Briviact · CONTRAVE · DAYBUE · DUOPA · DYSPORT · Dhivy · EMGALITY · EPIDIOLEX · Enspryng · FIRDAPSE · FYCOMPA · Fintepla · GAMMAGARD · GENERAL PAIN MANAGEMENT · GOCOVRI · General - DBS · Gocovri · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · LEQEMBI · Leqembi · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · Ocrevus · PERCEPT PC BRAINSENSE · PLEGRIDY · PURIFIED CORTROPHIN GEL · QULIPTA · RADICAVA · RYTARY · Rystiggo · SKYCLARYS · SOLIRIS · Senza · TEGSEDI · TOSYMRA · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VERCISE · VILTEPSO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · WATCHMAN Access System · Xeomin · ZEMBRACE SYMTOUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (56%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work.

Equivalent to $787 per 100 Medicare services performed
Looking for a neurology in Fort Worth?
Compare neurologys in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
80
Per 100K population
3.7
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Bostan Shirin is a mixed practice specialist, with above-average Medicare volume (top 13% in TX), and high industry engagement (research-focused, top 12%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Bostan Shirin experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Bostan Shirin performed 3,000 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bostan Shirin receive payments from pharmaceutical companies?
Yes. Dr. Bostan Shirin received a total of $35,690 from 50 companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bostan Shirin's costs compare to other neurologys in Fort Worth?
Dr. Bostan Shirin's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bostan Shirin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →